Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Multidrug-resistant tuberculosis among previously treated patients in the Philippines.
Int J Tuberc Lung Dis. 2011 May;15(5):652-6. doi: 10.5588/ijtld.10.0400.
Int J Tuberc Lung Dis. 2011.
PMID: 21756517
Screening outcomes from patients with suspected multidrug-resistant tuberculosis: lessons learned in the Philippines.
Gler MT, Guilatco RS, Guray CV, Tupasi TE.
Gler MT, et al. Among authors: guilatco rs.
Int J Tuberc Lung Dis. 2012 Oct;16(10):1326-30. doi: 10.5588/ijtld.12.0038. Epub 2012 Aug 3.
Int J Tuberc Lung Dis. 2012.
PMID: 22863522
Item in Clipboard
Significant decline in the tuberculosis burden in the Philippines ten years after initiating DOTS.
Tupasi TE, Radhakrishna S, Chua JA, Mangubat NV, Guilatco R, Galipot M, Ramos G, Quelapio MI, Beltran G, Legaspi J, Vianzon RG, Lagahid J.
Tupasi TE, et al. Among authors: guilatco r.
Int J Tuberc Lung Dis. 2009 Oct;13(10):1224-30.
Int J Tuberc Lung Dis. 2009.
PMID: 19793426
Item in Clipboard
Weight gain and response to treatment for multidrug-resistant tuberculosis.
Gler MT, Guilatco R, Caoili JC, Ershova J, Cegielski P, Johnson JL.
Gler MT, et al. Among authors: guilatco r.
Am J Trop Med Hyg. 2013 Nov;89(5):943-9. doi: 10.4269/ajtmh.13-0011. Epub 2013 Sep 9.
Am J Trop Med Hyg. 2013.
PMID: 24019430
Free PMC article.
Item in Clipboard
Measuring socio-economic data in tuberculosis prevalence surveys.
van Leth F, Guilatco RS, Hossain S, Van't Hoog AH, Hoa NB, van der Werf MJ, Lönnroth K.
van Leth F, et al. Among authors: guilatco rs.
Int J Tuberc Lung Dis. 2011 Jun;15 Suppl 2:58-63. doi: 10.5588/ijtld.10.0417.
Int J Tuberc Lung Dis. 2011.
PMID: 21740660
Item in Clipboard
Switching from Epoetin Alfa (Epogen®) to Epoetin Alfa-Epbx (RetacritTM) Using a Specified Dosing Algorithm: A Randomized, Non-Inferiority Study in Adults on Hemodialysis.
Thadhani R, Guilatco R, Hymes J, Maddux FW, Ahuja A.
Thadhani R, et al. Among authors: guilatco r.
Am J Nephrol. 2018;48(3):214-224. doi: 10.1159/000492621. Epub 2018 Sep 7.
Am J Nephrol. 2018.
PMID: 30196301
Free PMC article.
Clinical Trial.
Item in Clipboard
Real-life drug persistence in patients with rheumatic diseases treated with CT-P13: a prospective observational cohort study (PERSIST).
Taylor PC, Christensen R, Moosavi S, Selema P, Guilatco R, Fowler H, Mueller M, Liau KF, Haraoui B.
Taylor PC, et al. Among authors: guilatco r.
Rheumatol Adv Pract. 2021 Apr 23;5(2):rkab026. doi: 10.1093/rap/rkab026. eCollection 2021.
Rheumatol Adv Pract. 2021.
PMID: 34377890
Free PMC article.
Item in Clipboard
Three-year safety observation of subcutaneous administration of epoetin-zeta in patients with chronic renal anemia: Results from PASCO II study.
Patsialas S, Fowler H, Guilatco R, Salts S, Xia FR, Gomez Perez S, Iwanowitsch A, Kohnle M.
Patsialas S, et al. Among authors: guilatco r.
Clin Nephrol. 2023 May;99(5):247-255. doi: 10.5414/CN110825.
Clin Nephrol. 2023.
PMID: 36871229
Free PMC article.
Item in Clipboard
Cite
Cite